News and Events

Developing a novel drug requires understanding not only compound activity toward the biological target but also how it behaves within the body once administered.

As we approach the end of the year, now is the right time to secure the compounds you need to close 2025 on track - and start 2026 without delays.

The journey of developing a new medicine begins with understanding the biological mechanisms of the disease.

For your year-end discovery campaign, get special discounts on their ready-to-use OpenDEL™. The more kits you select, the higher the discount - up to 20% off.

Pritelivir is an AiCuris Anti-infective Cures AG's first-in-class antiviral small molecule targeting the helicase-primase complex, which is an essential for herpes simplex virus (HSV) DNA replication.

Unlock a 10% discount on all Enamine REAL and Chemspace Freedom compounds - available only until December 31!

Meet Olga Tarkhanova, PhD, and Anna Kapeliukha at the upcoming Advances in Screening Technologies for Drug Discovery meeting in Paris on December 5th - organized by the Société de Chimie Thérapeutique (SCT) and ChemBioFrance.

In past decades, computer-aided drug design has fundamentally changed the drug discovery landscape. One of the most powerful strategies has become virtual screening.

Join us tomorrow for the joint webinar by Chemspace and Paul Scherrer Institute (PSI) - “REAL Fragments, Real Crystals: Integrated Fragment Discovery with Chemspace and SLS.”

Modern techniques have made the size of combinatorial spaces no longer a limitation.

Over the past few years, the pharmaceutical industry has started to feel the impact of a technology actively used in art and design studios.

Chemspace is sponsoring the Machine Learning in Drug Discovery Symposium organized by the Broad Institute!

We have upgraded the way Chemspace explores make-on-demand chemical spaces!

We are excited to announce the upcoming Chemspace webinar co-hosted with Dr. May Sharpe from Paul Scherrer Institute: "REAL Fragments, Real Crystals: Integrated Fragment Discovery with Chemspace and SLS".

Drug discovery has always involved long waiting, high costs, and uncertainty. Promising molecules often fail, and years of work may lead to no viable result. This is one reason researchers keep turning to new tools.

This November, Chemspace is joining the global biotech community at BIO-Europe 2025 - where partnerships begin and innovations take shape.

We are excited to announce that Uliana Matviienko and Inna Volkova will attend CPHI 2025, one of the world’s leading pharmaceutical events bringing together innovators, manufacturers, and service providers shaping the future of pharma.

At Chemspace, we believe that behind every molecule and every research project, there is human health.

Lead optimization transforms an initial active molecule into a true drug candidate by fine-tuning its structure, balancing activity, safety, and stability to unlock real therapeutic potential.

We are excited to share that our latest publication on Freedom Space 3.0 is now out!

This fall, Chemspace brings you an exclusive offer: 3D shape-based similarity screening of 1.76M compounds from Enamine Screening Collection - only 5,000 USD. 

Discovering new medicines has always been a challenge with an asterisk. The journey from an early idea in the lab to a finished drug on the market with traditional research methods usually takes years of hard work and enormous human and financial effort.

Join Olena Mishchuk, PhD, and Inna Volkova at BioJapan - the premier bio-industry partnering event - taking place in Yokohama, Japan, on October 8–10.

Chemspace is the largest online catalog of small molecules and biologics! With every update, we make this universe of chemistry even bigger and easier to navigate.

Cucurbiturils have become a subject of considerable interest within supramolecular chemistry, attributable to their distinctive host-guest characteristics and broad applicability across domains such as drug delivery, catalysis, molecular recognition, and materials science.